Norihisa Nishida Selected Research

tiliroside

6/2013	Rosehip Extract Inhibits Lipid Accumulation in White Adipose Tissue by Suppressing the Expression of Peroxisome Proliferator-activated Receptor Gamma.
3/2012	Tiliroside, a glycosidic flavonoid, inhibits carbohydrate digestion and glucose absorption in the gastrointestinal tract.
6/2007	Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Norihisa Nishida Research Topics

Disease

4	Body Weight (Weight, Body) 01/2015 - 07/2002
2	Obesity 07/2019 - 06/2013
1	Mental Fatigue 10/2020
1	Fatigue 10/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2019
1	Arteriosclerosis 09/2015
1	Diabetes Complications 09/2015
1	Hyperinsulinism (Hyperinsulinemia) 03/2012
1	Neoplasms (Cancer) 01/2012
1	Stomatitis 01/2012

Drug/Important Bio-Agent (IBA)

3	tilirosideIBA 06/2013 - 06/2007
2	paramylonIBA 10/2020 - 07/2019
1	AntioxidantsIBA 10/2020
1	Biological ProductsIBA 10/2020
1	PowdersIBA 07/2019
1	GlucansIBA 07/2019
1	Dietary Fiber FDA Link 07/2019
1	Advanced Glycation End ProductsIBA 09/2015
1	TabletsIBA 01/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2013
1	Starch (Cornstarch)IBA 03/2012
1	Allopurinol (Remid)FDA LinkGeneric 01/2012
1	Dosage Forms (Dosage Form)IBA 01/2012
1	astragalinIBA 06/2007
1	p-coumaric acidIBA 06/2007
1	Blood Glucose (Blood Sugar)IBA 06/2007
1	kaempferolIBA 06/2007
1	AcetoneIBA 06/2007
1	Glucose (Dextrose)FDA LinkGeneric 06/2007
1	salvinIBA 04/2004

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2012
1	Radiotherapy 01/2012
1	Oral Administration 07/2002